# Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

> **NCT06029218** · NA · RECRUITING · sponsor: **Centre Antoine Lacassagne** · enrollment: 106 (estimated)

## Conditions studied

- Chordoma
- Chondrosarcoma
- Ewing Sarcoma
- Osteosarcoma

## Interventions

- **RADIATION:** Proteus ONE one daily beam
- **RADIATION:** Proteus ONE two daily beam

## Key facts

- **NCT ID:** NCT06029218
- **Lead sponsor:** Centre Antoine Lacassagne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-13
- **Primary completion:** 2026-09-01
- **Final completion:** 2031-10-01
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2024-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029218, "Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06029218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*